Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1957 1
1966 2
1967 2
1970 2
1971 3
1972 2
1974 2
1975 2
1976 1
1980 1
1981 1
1982 1
1983 1
1985 1
1988 2
1989 2
1992 1
1993 1
1994 2
1995 1
1996 2
1997 2
1998 3
1999 1
2000 2
2001 2
2002 1
2003 2
2004 4
2005 3
2006 1
2007 2
2008 10
2009 8
2010 7
2011 4
2012 8
2013 12
2014 15
2015 17
2016 21
2017 16
2018 16
2019 23
2020 24
2021 29
2022 38
2023 24
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

294 results

Results by year

Filters applied: . Clear all
Page 1
Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia.
Farber A, Menard MT, Conte MS, Kaufman JA, Powell RJ, Choudhry NK, Hamza TH, Assmann SF, Creager MA, Cziraky MJ, Dake MD, Jaff MR, Reid D, Siami FS, Sopko G, White CJ, van Over M, Strong MB, Villarreal MF, McKean M, Azene E, Azarbal A, Barleben A, Chew DK, Clavijo LC, Douville Y, Findeiss L, Garg N, Gasper W, Giles KA, Goodney PP, Hawkins BM, Herman CR, Kalish JA, Koopmann MC, Laskowski IA, Mena-Hurtado C, Motaganahalli R, Rowe VL, Schanzer A, Schneider PA, Siracuse JJ, Venermo M, Rosenfield K; BEST-CLI Investigators. Farber A, et al. N Engl J Med. 2022 Dec 22;387(25):2305-2316. doi: 10.1056/NEJMoa2207899. Epub 2022 Nov 7. N Engl J Med. 2022. PMID: 36342173 Clinical Trial.
Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.
Stone GW, Kappetein AP, Sabik JF, Pocock SJ, Morice MC, Puskas J, Kandzari DE, Karmpaliotis D, Brown WM 3rd, Lembo NJ, Banning A, Merkely B, Horkay F, Boonstra PW, van Boven AJ, Ungi I, Bogáts G, Mansour S, Noiseux N, Sabaté M, Pomar J, Hickey M, Gershlick A, Buszman PE, Bochenek A, Schampaert E, Pagé P, Modolo R, Gregson J, Simonton CA, Mehran R, Kosmidou I, Généreux P, Crowley A, Dressler O, Serruys PW; EXCEL Trial Investigators. Stone GW, et al. N Engl J Med. 2019 Nov 7;381(19):1820-1830. doi: 10.1056/NEJMoa1909406. Epub 2019 Sep 28. N Engl J Med. 2019. PMID: 31562798 Free article. Clinical Trial.
Changes in Bone Quality after Treatment with Etelcalcetide.
Khairallah P, Cherasard J, Sung J, Agarwal S, Aponte MA, Bucovsky M, Fusaro M, Silberzweig J, Frumkin GN, El Hachem K, Schulman L, McMahon D, Allen MR, Metzger CE, Surowiec RK, Wallace J, Nickolas TL. Khairallah P, et al. Among authors: metzger ce. Clin J Am Soc Nephrol. 2023 Nov 1;18(11):1456-1465. doi: 10.2215/CJN.0000000000000254. Epub 2023 Aug 14. Clin J Am Soc Nephrol. 2023. PMID: 37574661
C-reactive protein and D-dimer in cerebral vein thrombosis: Relation to clinical and imaging characteristics as well as outcomes in a French cohort study.
Billoir P, Siguret V, Fron EM, Drouet L, Crassard I, Marlu R, Barbieux-Guillot M, Morange PE, Robinet E, Metzger C, Wolff V, André-Kerneis E, Klapczynski F, Martin-Bastenaire B, Pico F, Menard F, Ellie E, Freyburger G, Rouanet F, Allano HA, Godenèche G, Mourey G, Moulin T, Berruyer M, Derex L, Trichet C, Runavot G, Le Querrec A, Viader F, Cluet-Dennetiere S, Husein TT, Donnard M, Macian-Montoro F, Ternisien C, Guillon B, Laplanche S, Zuber M, Peltier JY, Tassan P, Roussel B, Canaple S, Scavazza E, Gaillard N, Triquenot Bagan A, Le Cam Duchez V. Billoir P, et al. Among authors: metzger c. Res Pract Thromb Haemost. 2023 Mar 28;7(3):100130. doi: 10.1016/j.rpth.2023.100130. eCollection 2023 Mar. Res Pract Thromb Haemost. 2023. PMID: 37138790 Free PMC article.
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.
Siempos II, Kalil AC, Belhadi D, Veiga VC, Cavalcanti AB, Branch-Elliman W, Papoutsi E, Gkirgkiris K, Xixi NA, Kotanidou A, Hermine O, Porcher R, Mariette X; CORIMUNO-19 Collaborative Group; DisCoVeRy Study Group; ACTT-2 Study Group; ACTT-3 Study Group. Siempos II, et al. EClinicalMedicine. 2024 Feb 9;69:102472. doi: 10.1016/j.eclinm.2024.102472. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38361992 Free PMC article.
Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer's disease: results from the DELCODE study.
Brosseron F, Maass A, Kleineidam L, Ravichandran KA, Kolbe CC, Wolfsgruber S, Santarelli F, Häsler LM, McManus R, Ising C, Röske S, Peters O, Cosma NC, Schneider LS, Wang X, Priller J, Spruth EJ, Altenstein S, Schneider A, Fliessbach K, Wiltfang J, Schott BH, Buerger K, Janowitz D, Dichgans M, Perneczky R, Rauchmann BS, Teipel S, Kilimann I, Görß D, Laske C, Munk MH, Düzel E, Yakupow R, Dobisch L, Metzger CD, Glanz W, Ewers M, Dechent P, Haynes JD, Scheffler K, Roy N, Rostamzadeh A, Spottke A, Ramirez A, Mengel D, Synofzik M, Jucker M, Latz E, Jessen F, Wagner M, Heneka MT; DELCODE study group. Brosseron F, et al. Among authors: metzger cd. Alzheimers Res Ther. 2023 Jan 12;15(1):13. doi: 10.1186/s13195-022-01118-0. Alzheimers Res Ther. 2023. PMID: 36631909 Free PMC article.
Thalamic Dysmetria.
Menard R, Shah A, Metzger C, Altschuler EL. Menard R, et al. Among authors: metzger c. PM R. 2016 Mar;8(3):291-2. doi: 10.1016/j.pmrj.2015.07.017. Epub 2015 Aug 14. PM R. 2016. PMID: 26278997 No abstract available.
The Role of Osteocytes in Inflammatory Bone Loss.
Metzger CE, Narayanan SA. Metzger CE, et al. Front Endocrinol (Lausanne). 2019 May 14;10:285. doi: 10.3389/fendo.2019.00285. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31139147 Free PMC article. Review.
294 results